HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UVA Labeling "Pass/Fail" System Least Confusing To Consumers - P&G

This article was originally published in The Rose Sheet

Executive Summary

UVA sunscreen labeling should be based on a descriptive "pass/fail" system that categorizes products as "broad-spectrum" without designating a specific level of UVA protection, Procter & Gamble Senior Scientist Jay Nash, PhD, suggested.

You may also be interested in...



UVA Critical Wavelength Testing Plus In Vivo Method Recommended By AAD

In vitro critical wavelength testing should be combined with an in vivo method for determining UVA protec- tion in sunscreens, the American Academy of Dermatology opines in a set of "final" recommendations on UVA sunscreen protection published in the March Journal of the American Academy of Dermatology.

UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey

Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light in a study conducted by Brian Diffey, Newcastle General Hospital, England, et al., and published in the December Journal of the American Academy of Dermatology.

UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey

Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light in a study conducted by Brian Diffey, Newcastle General Hospital, England, et al., and published in the December Journal of the American Academy of Dermatology.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel